Serotonin Stimulates the Expression of Thrombin Receptors in Cultured Vascular Smooth Muscle Cells: Role of Protein Kinase C and Protein Tyrosine Kinases

Circulation

Volumn 93, Issue 12, 1996, Pages 2170-2177

  Schini Kerth, Valérie B ^a   Fisslthaler, Beate ^a   Van Obberghen Schilling, Ellen ^b   Busse, Rudi ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b CENTRE DE BIOCHIMIE   (France)

Author keywords

Arteriosclerosis; Muscle, smooth; Receptors, thrombin; Serotonin

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; MESSENGER RNA; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; SEROTONIN; SEROTONIN ANTAGONIST; THROMBIN RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; SEROTONIN RECEPTOR; THROMBIN;

ANIMAL; ARTICLE; CELL CULTURE; DRUG EFFECT; GENETICS; MALE; METABOLISM; PHYSIOLOGY; RAT; VASCULAR SMOOTH MUSCLE; WISTAR RAT; ANIMAL CELL; ANIMAL TISSUE; ARTERIOSCLEROSIS; ARTERY INTIMA PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; THROMBOCYTE AGGREGATION;

6-KETOPROSTAGLANDIN F1 ALPHA; ANIMALS; CELLS, CULTURED; MALE; MUSCLE, SMOOTH, VASCULAR; PROTEIN KINASE C; PROTEIN-TYROSINE KINASES; RATS; RATS, WISTAR; RECEPTORS, THROMBIN; RNA, MESSENGER; SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 0029665622     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.12.2170     Document Type: Article

References (59)

1. Friedman RJ, Stemerman MB, Wenz B, Moore S, Gauldie J, Gent M, Tiell ML, Spaet TH. The effect of thrombocytopenia on experimental arteriosclerotic lesion formation in rabbits: smooth muscle cell proliferation and re-endothelialization. J Clin Invest. 1977;60: 1191-1201.
2. Walker LN, Bowen-Pope DF, Ross R, Reidy MA. Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. Proc Natl Acad Sci U S A. 1986;83:7311-7315.
3. Sarembock IJ, Gertz SD, Gimple LW, Owen RM, Powers ER, Roberts WC. Effectiveness of recombinant desulphatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. Circulation. 1991;84:232-243.
4. Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA. Role of fibroblast growth factor in vascular lesion formation. Circ Res. 1991; 68:106-113.
5. Hatton MWC, Moar SL, Richardson M. Deendothelialization in vivo initiates a thrombogenic reaction at the rabbit aorta surface: correlation of uptake of fibrinogen and antithrombin III with thrombin generation by the exposed subendothelium. Am J Pathol. 1989;135:499-508.
6. Wilentz JR, Sanborn TA, Haudenschild CC, Valeri CR, Ryan TJ, Faxon DP. Platelet accumulation in experimental angioplasty: time course and relation to vascular injury. Circulation. 1987;75:636-642.
7. Holmsen H. Platelet secretion and energy metabolism. In: Colman RW, Hirsch J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia, Pa: JB Lippincott Co; 1993:524-545.
8. Herbert JM, Lamarche I, Dol F. Induction of vascular smooth muscle cell growth by selective activation of the thrombin receptor: effect of heparin. FEBS Lett. 1992;301:155-158.
9. Okazaki H, Majesky MW, Harker LA, Schwartz SM. Regulation of platelet-derived growth factor ligand and receptor gene expression by α-thrombin in vascular smooth muscle cells. Circ Res. 1992;71: 1285-1293.
10. Gasic GP, Arenas CP, Gasic TB, Gasic GJ. Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells. Proc Natl Acad Sci U S A. 1992;89:2317-2320.
11. Majesky MW, Reidy MA, Bowen-Pope DF, Hart CE, Wilcox JN, Schwartz SM. PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol. 1990;111:2149-2158.
12. McNamara CA, Sarembock IJ, Gimple LW, Fenton JW II, Coughlin SR, Owens GK. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest. 1993;91:94-98.
13. Walters TK, Gorog DA, Wood RFM. Thrombin generation following arterial injury is a critical initiating event in the pathogenesis of the proliferative stages of the atherosclerotic process. J Vasc Res. 1994;31:173-177.
14. Vu T-KH, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 1991;64:1057-1068.
15. 2+ mobilization. FEBS Lett. 1991;288:123-128.
16. Vouret-Craviari V, Van Obberghen-Schilling E, Rasmussen UB, Pavirani A, Lecocq J-P, Pouysségur J. Synthetic α-thrombin receptor peptides activate G protein-coupled signaling pathways but are unable to induce mitogenesis. Mol Biol Cell. 1992;3:95-102.
17. Brass LF. Homologous desensitization of HEL cell thrombin receptors: distinguishable roles for proteolysis and phosphorylation. J Biol Chem. 1992;267:6044-6050.
18. Hoxie JA, Ahuja M, Belmonte E, Pizarro S, Parton R, Brass LF. Internalization and recycling of activated thrombin receptors. J Biol Chem. 1993;268:13756-13763.
19. Hein L, Ishii K, Coughlin SR, Kobilka BK. Intracellular targeting and trafficking of thrombin receptors: a novel mechanism for resensitization of a G protein-coupled receptor. J Biol Chem. 1994;269: 27719-27726.
20. Nelken NA, Soifer SJ, O'Keefe J, Vu T-KH, Charo IF, Coughlin SR. Thrombin receptor expression in normal and atherosclerotic human arteries. J Clin Invest. 1992;90:1614-1621.
21. Wilcox JN, Rodriguez J, Subramanian R, Ollerenshaw J, Zhong C, Hayzer DJ, Horaist C, Hanson SR, Lumsden A, Salam TA, Kelly AB, Harker LA, Runge M. Characterization of thrombin receptor expression during vascular lesion formation. Circ Res. 1994;75: 1029-1038.
22. Pakala R, Willerson JT, Benedict CR. Mitogenic effect of serotonin on vascular endothelial cells. Circulation. 1994;90:1919-1926.
23. Scott-Burden T, Resink TJ, Baur U, Burgin M, Buhler FR. Epidermal growth factor responsiveness in smooth muscle cells from hypertensive and normotensive rats. Hypertension. 1989;13:295-304.
24. ++ channels and phospholipase C. J Pharmacol Exp Ther. 1985;234:442-446.
25. 5 smooth muscle cells. Naunyn Schmiedebergs Arch Pharmacol. 1986;333:98-103.
26. Lee S-L, Wang WW, Lanzillo JJ, Fanburg BL. Regulation of serotonin-induced DNA synthesis of bovine pulmonary artery smooth muscle cells. Am J Physiol. 1994;266:L53-L60.
27. Davis PD, Hill CH, Keech E, Lawton G, Nixon JS, Sedgwick AD, Wadsworth J, Westmacott D, Wilkinson SE. Potent selective inhibitors of protein kinase C. FEBS Lett. 1989;259:61-63.
28. 2+-sensitive, phospholipid-dependent protein kinase activity in phorbol ester-treated 3T3 cells. Biochem Biophys Res Commun. 1984;120: 1053-1059.
29. Geissler JF, Traxler P, Regemass U, Murray BJ, Roesel JL, Meyer T, McGlynn E, Storni A, Lydon NB. Thiazolidine-diones: biochemical and biological activity of a novel class of tyrosine protein kinase inhibitors. J Biol Chem. 1990;265:22255-22261.
30. Schini-Kerth VB, Fisslthaler B, Andersen TT, Fenton JW II, Vanhoutte PM, Busse R. Thrombin prevents the expression of inducible nitric oxide synthase in vascular smooth muscle cells by a proteolytically-activated thrombin receptor. Thromb Haemost. 1995;74:980-986.
31. Hysmith RM, Boor PJ. In vitro expression of benzylamine oxidase activity in cultured porcine smooth muscle cells. J Cardiovasc Pharmacol. 1987;9:668-674.
32. Lee S-L, Dunn J, Yu F-S, Fanburg BL. Serotonin uptake and configurational change of bovine pulmonary artery smooth muscle cells in culture. J Cell Physiol. 1989;138:145-153.
33. Lee SL, Wang WW, Moore BJ, Fanburg BL. Dual effect of serotonin on growth of bovine pulmonary artery smooth muscle cells in culture. Circ Res. 1991;68:1362-1368.
34. 2 receptor-stimulated inositol phosphate formation in rat aortic myocytes. Eur J Pharmacol. 1986;131:153-157.
35. McGoon MD, Vanhoutte PM. Aggregating platelets contract isolated canine pulmonary arteries by releasing 5-hydroxytryptamine. J Clin Invest. 1984;74:828-833.
36. 2, and adenine nucleotides. J Clin Invest. 1986;78:539-544.
37. 2 receptors mediating contraction on vascular smooth muscle. J Pharmacol Exp Ther. 1981;218:421-425.
38. Godfraind T, Dessy C, Salomone S. A comparison of the potency of selective L-calcium channel blockers in human coronary and internal mammary arteries exposed to serotonin. J Pharmacol Exp Ther. 1992;263:112-122.
39. Kaumann AJ, Parsons AA, Brown AM. Human arterial constrictor serotonin receptors. Cardiovasc Res. 1993;27:2094-2103.
40. Nemecek GM, Coughlin SR, Handley DA, Moskowitz MA. Stimulation of aortic smooth muscle cell mitogenesis by serotonin. Proc Natl Acad Sci U S A. 1986;83:674-678.
41. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PPA. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev. 1994;46:157-203.
42. 2 serotonergic receptors. J Pharmacol Exp Ther. 1981;218:217-230.
43. Houston DS, Vanhoutte PM. Comparison of serotonergic receptor subtypes on the smooth muscle and endothelium of the canine coronary artery. J Pharmacol Exp Ther. 1981;244:1-10.
44. Parsons AA 5-HT receptors in human and animal cerebrovasculature. Trends Pharmacol Sci. 1991;12:310-315.
45. Araki S-I, Kawahara Y, Fukuzaki H, Takai Y. Serotonin plays a major role in serum-induced phospholipase C-mediated hydrolysis of phosphoinositides and DNA synthesis in vascular smooth muscle cells. Atherosclerosis. 1990;83:29-34.
46. Parrot DP, Lockey PM, Bright CP. Comparison of the mitogenic activity of angiotensin II and serotonin on porcine arterial smooth muscle cells. Atherosclerosis. 1991;88:213-218.
47. Uehara Y, Nagata T, Matsuoka H, Namabe A, Hirawa N, Takada S, Ishimitsu T, Yagi S, Sugimoto T. Antiproliferative effects of the serotonin type 2 receptor antagonist, ketanserin, on smooth muscle cell growth in rats. J Cardiovasc Pharmacol. 1991;17:S154-S156.
48. Bell L, Madri JA. Effect of platelet factors on migration of cultured bovine aortic endothelial and smooth muscle cells. Circ Res. 1989; 65:1057-1065.
49. Pritchett DB, Bach AWJ, Wozny M, Taleb O, Dal Toso R, Shih JC, Seeburg PH. Structure and functional expression of cloned rat serotonin 5HT-2 receptor. EMBO J. 1988;7:4135-4140.
50. Julius D, Huang KN, Livelli TJ, Axel R, Jessell TM. The 5HT2 receptor defines a family of structurally distinct but functionally conserved serotonin receptors. Proc Natl Acad Sci U S A. 1990;87: 928-932.
51. Van Obberghen-Schilling E, Vouret-Craviari V, Haslam RJ, Chambard J-C, Pouysségur J. Cloning, functional expression and role in cell growth regulation of a hamster 5-HT2 receptor subtype. Mol Endocrinol. 1991;5:881-889.
52. Roth BL, Nakaki T, Chuang DM, Costa E. Aortic recognition sites for serotonin are coupled to phospholipase C and modulate phosphatidylinositol turnover. Neuropharmacology. 1984;23: 1223-1225.
53. Ashton JH, Benedict CR, Fitzgerald C, Raheja S, Taylor A, Campbell WB, Buja LM, Willerson JT. Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries. Circulation. 1986;73:572-578.
54. Benedict CR, Mathew B, Rex KA, Cartwright J Jr, Sordahl LA. Correlation of plasma serotonin changes with platelet aggregation in an in vivo dog model of spontaneous occlusive thrombus formation. Circ Res. 1986;58:58-67.
55. van den Berg EK, Schmitz JM, Benedict CR, Malloy CR, Willerson JT, Dehmer GJ. Transcardiac serotonin concentration is increased in selected patients with limiting and complex coronary lesion morphology. Circulation. 1989;79:116-124.
56. Golino P, Piscione F, Willerson JT, Cappelli-Bigazzi M, Focaccio A, Villari B, Indolfi C, Russolillo E, Condorelli M, Chiariello M. Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. N Engl J Med. 1991;324:641-648.
57. Cohen RA. Adenine nucleotides and 5-hydroxytryptamine released by aggregating platelets inhibit adrenergic neurotransmission in canine coronary artery. J Clin Invest. 1986;77:369-375.
58. Lindner V, Reidy A. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci U S A. 1991;88:3739-3743.
59. Zhong C, Hayzer DJ, Corson MA, Runge MS. Molecular cloning of the rat vascular smooth muscle thrombin receptor: evidence for in vitro regulation by basic fibroblast growth factor. J Biol Chem. 1992; 267:16975-16979.